MedPath

Renoprotective effect of combination therapy in hypertensive patients with renal diseases.

Not Applicable
Conditions
Hypertensive patients with renal diseases
Registration Number
JPRN-UMIN000002752
Lead Sponsor
Division of nephrology, Kanazawa University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Uncontrolled hypertension (systolic blood pressure >200 mmHg) No use of carcium channel blocker or diuretics within 1 month Pregnancy or its possibility Hypersensitivity to or contraindication of olmesartan

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath